<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0375361</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4604</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Psychol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">J Child Psychol Psychiatry</journal-id>
<journal-title-group>
<journal-title>Journal of child psychology and psychiatry, and allied disciplines</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9630</issn>
<issn pub-type="epub">1469-7610</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28921525</article-id>
<article-id pub-id-type="pmc">5812799</article-id>
<article-id pub-id-type="doi">10.1111/jcpp.12815</article-id>
<article-id pub-id-type="manuscript">NIHMS899807</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Comorbid Symptoms of Inattention, Autism and Executive Cognition in Youth with Putative Genetic Risk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Arnett</surname>
<given-names>Anne B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cairney</surname>
<given-names>Brianna E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wallace</surname>
<given-names>Arianne S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gerdts</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turner</surname>
<given-names>Tychele N.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eichler</surname>
<given-names>Evan E.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernier</surname>
<given-names>Raphael A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>University of Washington, Department of Psychiatry</aff>
<aff id="A2">
<label>2</label>University of Washington, Department of Genome Sciences</aff>
<aff id="A3">
<label>3</label>University of Washington, Department of Genome Sciences and Howard Hughes Medical Institute</aff>
<author-notes>
<corresp id="FN1">Correspondence to: Anne B. Arnett, Ph.D., University of Washington, CHDD Box 357920, Seattle, WA 98195, <email>Arnett.anne@gmail.com</email>, p. (978) 886-1658</corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>CONFLICT OF INTERESTS</bold>
</p>
<p>E.E.E. is on the scientific advisory board (SAB) of DNAnexus, Inc.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>59</volume>
<issue>3</issue>
<fpage>268</fpage>
<lpage>276</lpage>
<!--elocation-id from pubmed: 10.1111/jcpp.12815-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">Symptoms of autism spectrum disorder (ASD) and inattention (IA) are highly comorbid and associated with deficits in executive cognition. Cognitive deficits have been posited as candidate endophenotypes of psychiatric traits, but few studies have conceptualized cognitive deficits as psychiatric comorbidities. The latter model is consistent with a latent factor reflecting broader liability to neuropsychological dysfunction, and explains heterogeneity in the cognitive profile of individuals with ASD and IA</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">We tested competing models of covariance among symptoms of ASD, IA, and cognition in a sample of 73 youth with a known genetic mutation</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">A common executive factor fit best as a cognitive comorbidity, rather than endophenotype, of the shared variance between measures of IA and ASD symptoms. Known genetic risk explained a third of the shared variance among psychiatric and cognitive measures</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">Comorbid symptoms of ASD, IA and cognitive deficits are likely influenced by common neuro-genetic factors. Known genetic risk in ASD may inform future investigation of putative genetic causes of IA.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>